Health Catalyst, Inc.

Name: Health Catalyst, Inc. standardized financial statements, quarterly
Creator: Listed

HCATNasdaqCIK 1636422TechnologyFiscal year ends Dec 31

Share this page

Link

Story card, 1080 × 1920

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Revenue$70.5m, Q2 FY2026

Operating income−$36.5m, Q2 FY2026

Net income−$40.5m, Q2 FY2026

Health Catalyst, Inc., income statement, quarterly
Line item	Unit	Q3 FY20232023-09-30	Q4 FY20232023-12-31	Q1 FY20242024-03-31	Q2 FY20242024-06-30	Q3 FY20242024-09-30	Q4 FY20242024-12-31	Q1 FY20252025-03-31	Q2 FY20252025-06-30	Q3 FY20252025-09-30	Q4 FY20252025-12-31	Q1 FY20262026-03-31	Q2 FY20262026-06-30
Revenue	$m	73.8	75.1	74.7	75.9	76.4	79.6	79.4	80.7	76.3	74.7	70.8	70.5
Gross profit	$m	not reported	not reported	not reported	not reported	36.3	not reported	not reported	not reported	40.1	not reported	not reported	not reported
Research and development	$m	17.7	20.3	14.9	13.9	14.2	15.0	15.2	12.4	12.3	9.9	9.8	11.0
Operating income	$m	(24.6)	(32.8)	(22.8)	(15.8)	(13.7)	(17.5)	(20.2)	(37.1)	(17.5)	(86.1)	(106)	(36.5)
Income tax	$m	0.1	0.1	0.1	0.1	(0.5)	0.6	0.2	0.1	0.0	0.4	0.4	0.3
Net income	$m	(22.0)	(30.3)	(20.6)	(13.5)	(14.7)	(20.7)	(23.7)	(41.0)	(22.2)	(91.0)	(111)	(40.5)
Diluted EPS	$ per share	(0.39)	not reported	(0.35)	(0.23)	(0.24)	not reported	(0.35)	(0.59)	(0.32)	not reported	(1.53)	(0.55)
Basic EPS	$ per share	(0.39)	not reported	(0.35)	(0.23)	(0.24)	not reported	(0.35)	(0.59)	(0.32)	not reported	(1.53)	(0.55)

Balance sheet

Cash and equivalents$60.6m, Q2 FY2026

Long-term debt$151.9m, Q2 FY2026

Shareholders' equity$100.8m, Q2 FY2026

Health Catalyst, Inc., balance sheet, quarterly
Line item	Unit	Q3 FY20232023-09-30	FY20232023-12-31	Q1 FY20242024-03-31	Q2 FY20242024-06-30	Q3 FY20242024-09-30	FY20242024-12-31	Q1 FY20252025-03-31	Q2 FY20252025-06-30	Q3 FY20252025-09-30	FY20252025-12-31	Q1 FY20262026-03-31	Q2 FY20262026-06-30
Cash and equivalents	$m	95.0	106	201	202	328	250	342	50.7	40.3	50.8	59.9	60.6
Current assets	$m	408	393	397	376	457	466	423	181	165	169	182	248
Total assets	$m	713	702	695	692	813	859	892	616	587	503	412	359
Current liabilities	$m	84.3	89.0	92.2	318	324	326	340	98.8	87.9	89.6	108	91.9
Total liabilities	$m	331	335	338	335	458	494	515	269	255	257	274	258
Long-term debt	$m	228	228	228	0.0	115	151	151	151	152	152	152	152
Current portion of debt	$m	not reported	0.0	not reported	not reported	230	231	232	1.6	1.6	1.6	1.6	1.6
Shareholders' equity	$m	382	367	357	357	355	365	377	348	332	246	138	101

Cash flow

Operating cash flow$275.0k, Q2 FY2026

Capital expenditure$345.0k, Q2 FY2026

Share repurchases$0, Q2 FY2026

Health Catalyst, Inc., cash flow, quarterly
Line item	Unit	Q3 FY20232023-09-30	Q4 FY20232023-12-31	Q1 FY20242024-03-31	Q2 FY20242024-06-30	Q3 FY20242024-09-30	Q4 FY20242024-12-31	Q1 FY20252025-03-31	Q2 FY20252025-06-30	Q3 FY20252025-09-30	Q4 FY20252025-12-31	Q1 FY20262026-03-31	Q2 FY20262026-06-30
Operating cash flow	$m	3.1	(19.0)	10.3	1.6	6.2	(3.5)	0.3	(9.0)	(0.5)	9.9	18.5	0.3
Capital expenditure	$m	0.1	0.3	0.2	0.3	0.7	0.4	0.7	(0.2)	0.3	0.3	0.3	0.3
Share repurchases	$m	0.0	0.0	0.0	0.0	0.0	0.0	5.0	0.0	0.0	0.0	0.0	0.0

Diluted shares (weighted)73.96m, Q2 FY2026

Health Catalyst, Inc., shares, quarterly
Line item	Unit	Q3 FY20222022-09-30	Q1 FY20232023-03-31	Q2 FY20232023-06-30	Q3 FY20232023-09-30	Q1 FY20242024-03-31	Q2 FY20242024-06-30	Q3 FY20242024-09-30	Q1 FY20252025-03-31	Q2 FY20252025-06-30	Q3 FY20252025-09-30	Q1 FY20262026-03-31	Q2 FY20262026-06-30
Diluted shares (weighted)	m shares	54.3	55.5	56.0	56.7	58.6	59.3	60.4	68.6	69.6	70.4	72.6	74.0

Shares outstanding: 75.26m at Jul 31, 2026, from the cover of the 10-Q filed Aug 6, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:44 ET. Listed shows no prices and gives no investment advice.